News

April 24, 2023 /PRNewswire/ -- Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has approved the newest addition to its feline portfolio — NexGard ® COMBO ...
Boehringer Ingelheim announced that the US Food and Drug Administration (FDA) has approved the newest innovation from the trusted NexGard Brand of Products — NexGard PLUS (afoxolaner, moxidectin and ...
With advancements in veterinary medicine, pet owners now have access to effective solutions, such as Boehringer Ingelheim's NexGard® COMBO for cats. This groundbreaking, easy-to-apply formula provides ...
INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim, a leading research-driven biopharmaceutical company, continues to advance its pipeline in both Human Pharma and Animal Health expanding ...
The NexGard ® COMBO formulation is the latest example of Boehringer Ingelheim building on its history of leadership in animal health to provide advanced, preventive animal healthcare and develop ...